AEON Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
AEON Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2022 to Q2 2024.
  • AEON Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 38.8M shares, a 72% decline year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 38.8M -100M -72% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 37.3M -102M -73.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 37.2M -102M -73.2% Jul 22, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 139M Jul 1, 2023 Jul 21, 2023 10-Q/A 2024-03-29
Q2 2023 139M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 139M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 139M Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.